New Mutations Involved in Colistin Resistance in <named-content content-type="genus-species">Acinetobacter baumannii</named-content>
ABSTRACT Colistin is used as the “last resort” to treat infections caused by multidrug-resistant Acinetobacter baumannii, which is at the top of the World Health Organization’s list of the most dangerous bacterial species that threaten human health. Unfortunately, colistin resistance has emerged in...
Saved in:
Main Authors: | Bingbing Sun, Haiyan Liu, Yu Jiang, Lei Shao, Sheng Yang, Daijie Chen |
---|---|
Format: | article |
Language: | EN |
Published: |
American Society for Microbiology
2020
|
Subjects: | |
Online Access: | https://doaj.org/article/65316fb34dfe4f70aaea84a3b4a463a0 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Dissecting Colistin Resistance Mechanisms in Extensively Drug-Resistant <named-content content-type="genus-species">Acinetobacter baumannii</named-content> Clinical Isolates
by: Vincent Trebosc, et al.
Published: (2019) -
¿Se debe revisar la determinación de la CIM de colistín en Acinetobacter baumannii?
by: Villanueva,Xabier, et al.
Published: (2017) -
Prospective observational study of the impact of plasma colistin levels in patients with carbapenem-resistant Acinetobacter baumannii pneumonia
by: Yun-Jeong Jeong, et al.
Published: (2021) -
Aminoglycoside Heteroresistance in <named-content content-type="genus-species">Acinetobacter baumannii</named-content> AB5075
by: Sarah E. Anderson, et al.
Published: (2018) -
The H-NS Regulator Plays a Role in the Stress Induced by Carbapenemase Expression in <named-content content-type="genus-species">Acinetobacter baumannii</named-content>
by: Fanny Huang, et al.
Published: (2020)